Arcoma AB (ARCOMA) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.004x

Based on the latest financial reports, Arcoma AB (ARCOMA) has a cash flow conversion efficiency ratio of -0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-308.00K ≈ $-33.15K USD) by net assets (Skr73.39 Million ≈ $7.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Arcoma AB - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Arcoma AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Arcoma AB carry for a breakdown of total debt and financial obligations.

Arcoma AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Arcoma AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Clinical Laserthermia Systems AB (publ) ST:CLS-B	-0.161x
The Grob Tea Company Limited NSE:GROBTEA	-0.064x
Telecom Plus PLC LSE:TEP	0.263x
Holand og Setskog Sparebank OL:HSPG	0.251x
Yelooo Integra Datanet Tbk PT JK:YELO	-0.001x
iOThree Limited Ordinary Shares NASDAQ:IOTR	N/A
Cielo Waste Solutions Corp V:CMC	0.452x
Media Investment Optimization SL MC:MIO	-0.196x

Annual Cash Flow Conversion Efficiency for Arcoma AB (2012–2024)

The table below shows the annual cash flow conversion efficiency of Arcoma AB from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Arcoma AB market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr59.33 Million ≈ $6.39 Million	Skr18.84 Million ≈ $2.03 Million	0.318x	-19.34%
2023-12-31	Skr48.66 Million ≈ $5.24 Million	Skr19.16 Million ≈ $2.06 Million	0.394x	+10191.91%
2022-12-31	Skr45.88 Million ≈ $4.94 Million	Skr-179.00K ≈ $-19.26K	-0.004x	+91.11%
2021-12-31	Skr44.04 Million ≈ $4.74 Million	Skr-1.93 Million ≈ $-207.91K	-0.044x	-131.74%
2020-12-31	Skr49.53 Million ≈ $5.33 Million	Skr6.85 Million ≈ $736.74K	0.138x	-43.73%
2019-12-31	Skr45.19 Million ≈ $4.86 Million	Skr11.10 Million ≈ $1.19 Million	0.246x	+21208.34%
2018-12-31	Skr39.03 Million ≈ $4.20 Million	Skr45.00K ≈ $4.84K	0.001x	+100.53%
2017-12-31	Skr40.83 Million ≈ $4.39 Million	Skr-8.91 Million ≈ $-958.86K	-0.218x	-74.65%
2016-12-31	Skr37.35 Million ≈ $4.02 Million	Skr-4.67 Million ≈ $-502.14K	-0.125x	-26.04%
2015-12-31	Skr49.92 Million ≈ $5.37 Million	Skr-4.95 Million ≈ $-532.48K	-0.099x	-399.55%
2014-12-31	Skr41.73 Million ≈ $4.49 Million	Skr-828.00K ≈ $-89.11K	-0.020x	+97.90%
2013-12-31	Skr12.52 Million ≈ $1.35 Million	Skr-11.82 Million ≈ $-1.27 Million	-0.944x	-122.06%
2012-12-31	Skr24.14 Million ≈ $2.60 Million	Skr-10.27 Million ≈ $-1.10 Million	-0.425x	--

About Arcoma AB

ST:ARCOMA Sweden Medical Devices

Market Cap

$11.55 Million

Skr107.31 Million SEK

Market Cap Rank

#26507 Global

#571 in Sweden

Share Price

Skr7.50

Change (1 day)

+0.00%

52-Week Range

Skr6.92 - Skr10.75

All Time High

Skr25.60